207 related articles for article (PubMed ID: 29058301)
1. Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
Afsharpad M; Nowroozi MR; Mobasheri MB; Ayati M; Nekoohesh L; Saffari M; Zendehdel K; Modarressi MH
Pathol Oncol Res; 2019 Jan; 25(1):191-199. PubMed ID: 29058301
[TBL] [Abstract][Full Text] [Related]
2. ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma.
Afsharpad M; Nowroozi MR; Ayati M; Saffari M; Nemati S; Mohebbi E; Nekoohesh L; Zendehdel K; Modarressi MH
Iran Biomed J; 2018 May; 22(3):160-70. PubMed ID: 28865418
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder.
Yin B; Liu G; Wang XS; Zhang H; Song YS; Wu B
Urol Oncol; 2012; 30(6):886-92. PubMed ID: 21396841
[TBL] [Abstract][Full Text] [Related]
5. [Expression of melanoma antigen gene in urinary transitional cell carcinomas].
Geng L; Yu LZ; Du P; Ma M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943
[TBL] [Abstract][Full Text] [Related]
6. Potential molecular marker for detecting transitional cell carcinoma.
Chiu AW; Huang YL; Huan SK; Wang YC; Ju JP; Chen MF; Chou CK
Urology; 2002 Jul; 60(1):181-5. PubMed ID: 12100959
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Rath SK; Dalela D; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):103-8. PubMed ID: 25178936
[TBL] [Abstract][Full Text] [Related]
8. Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder.
Hazzaa SM; Elashry OM; Afifi IK
Pathol Oncol Res; 2010 Mar; 16(1):101-9. PubMed ID: 19757199
[TBL] [Abstract][Full Text] [Related]
9. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.
Yuasa T; Yoshiki T; Isono T; Tanaka T; Hayashida H; Okada Y
Int J Urol; 1999 Jun; 6(6):286-92. PubMed ID: 10404304
[TBL] [Abstract][Full Text] [Related]
10. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
11. S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand/RAGE axis in tumor progression?
Khorramdelazad H; Bagheri V; Hassanshahi G; Karami H; Moogooei M; Zeinali M; Abedinzadeh M
Asian Pac J Cancer Prev; 2015; 16(7):2725-9. PubMed ID: 25854354
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of maspin expression in bladder cancer.
Beecken WD; Engl T; Engels K; Blumenberg C; Oppermann E; Camphausen K; Shing Y; Reinecke G; Jonas D; Blaheta R
World J Urol; 2006 Aug; 24(3):338-44. PubMed ID: 16832651
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.
Lin YL; Sun G; Liu XQ; Li WP; Ma JG
J Int Med Res; 2011; 39(1):179-86. PubMed ID: 21672320
[TBL] [Abstract][Full Text] [Related]
14. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
15. [Expression of apoptosis inhibitor gene Livin in bladder transitional cell carcinoma and clinical implication thereof].
Song T; Hong BF; Gao JP; Cai W; Wang CY
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):806-7. PubMed ID: 17565859
[TBL] [Abstract][Full Text] [Related]
16. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
[TBL] [Abstract][Full Text] [Related]
19. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
Sharma P; Gnjatic S; Jungbluth AA; Williamson B; Herr H; Stockert E; Dalbagni G; Donat SM; Reuter VE; Santiago D; Chen YT; Bajorin DF; Old LJ
Cancer Immun; 2003 Dec; 3():19. PubMed ID: 14680360
[TBL] [Abstract][Full Text] [Related]
20. Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
Hotakainen K; Haglund C; Paju A; Nordling S; Alfthan H; Rintala E; Stenman UH
Eur Urol; 2002 Jun; 41(6):677-85. PubMed ID: 12074787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
